Epothilone B prevents lipopolysaccharide-induced inflammatory osteolysis through suppressing osteoclastogenesis via STAT3 signaling pathway - Figure f2 | Aging
![Umbelliferone Prevents Lipopolysaccharide-Induced Bone Loss and Suppresses RANKL-Induced Osteoclastogenesis by Attenuating Akt-c-Fos-NFATc1 Signaling Umbelliferone Prevents Lipopolysaccharide-Induced Bone Loss and Suppresses RANKL-Induced Osteoclastogenesis by Attenuating Akt-c-Fos-NFATc1 Signaling](https://www.ijbs.com/v15/p2427/toc.jpg)
Umbelliferone Prevents Lipopolysaccharide-Induced Bone Loss and Suppresses RANKL-Induced Osteoclastogenesis by Attenuating Akt-c-Fos-NFATc1 Signaling
![PKR regulates LPS‐induced osteoclast formation and bone destruction in vitro and in vivo - Teramachi - 2017 - Oral Diseases - Wiley Online Library PKR regulates LPS‐induced osteoclast formation and bone destruction in vitro and in vivo - Teramachi - 2017 - Oral Diseases - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/61ce3e24-b1c9-47e4-ba70-e36a1893444f/odi12592-fig-0002-m.jpg)
PKR regulates LPS‐induced osteoclast formation and bone destruction in vitro and in vivo - Teramachi - 2017 - Oral Diseases - Wiley Online Library
![Pam 2 and Pam3 stimulate mature osteoclast formation, whereas S. aureus, LPS P. gingivalis and HKLM stimulate differentiation of mononuclear osteoclasts in RANKL-primed bone marrow macrophage cultures. Pam 2 and Pam3 stimulate mature osteoclast formation, whereas S. aureus, LPS P. gingivalis and HKLM stimulate differentiation of mononuclear osteoclasts in RANKL-primed bone marrow macrophage cultures.](https://s3-eu-west-1.amazonaws.com/ppreviews-plos-725668748/5419271/preview.jpg)
Pam 2 and Pam3 stimulate mature osteoclast formation, whereas S. aureus, LPS P. gingivalis and HKLM stimulate differentiation of mononuclear osteoclasts in RANKL-primed bone marrow macrophage cultures.
![Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling | BMC Immunology | Full Text Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling | BMC Immunology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12865-021-00409-9/MediaObjects/12865_2021_409_Fig6_HTML.png)
Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling | BMC Immunology | Full Text
![Artesunate attenuates LPS-induced osteoclastogenesis by suppressing TLR4/TRAF6 and PLCγ1-Ca2+-NFATc1 signaling pathway | Acta Pharmacologica Sinica Artesunate attenuates LPS-induced osteoclastogenesis by suppressing TLR4/TRAF6 and PLCγ1-Ca2+-NFATc1 signaling pathway | Acta Pharmacologica Sinica](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41401-019-0289-6/MediaObjects/41401_2019_289_Fig1_HTML.png)
Artesunate attenuates LPS-induced osteoclastogenesis by suppressing TLR4/TRAF6 and PLCγ1-Ca2+-NFATc1 signaling pathway | Acta Pharmacologica Sinica
![IJMS | Free Full-Text | NLRP3 Inflammasome Negatively Regulates RANKL-Induced Osteoclastogenesis of Mouse Bone Marrow Macrophages but Positively Regulates It in the Presence of Lipopolysaccharides IJMS | Free Full-Text | NLRP3 Inflammasome Negatively Regulates RANKL-Induced Osteoclastogenesis of Mouse Bone Marrow Macrophages but Positively Regulates It in the Presence of Lipopolysaccharides](https://www.mdpi.com/ijms/ijms-23-06096/article_deploy/html/images/ijms-23-06096-g008-550.jpg)
IJMS | Free Full-Text | NLRP3 Inflammasome Negatively Regulates RANKL-Induced Osteoclastogenesis of Mouse Bone Marrow Macrophages but Positively Regulates It in the Presence of Lipopolysaccharides
![CGRP inhibits LPS induced-osteoclast differentiation in vitro.: (a) Raw... | Download Scientific Diagram CGRP inhibits LPS induced-osteoclast differentiation in vitro.: (a) Raw... | Download Scientific Diagram](https://www.researchgate.net/publication/305075089/figure/fig2/AS:391202202505248@1470281281940/CGRP-inhibits-LPS-induced-osteoclast-differentiation-in-vitro-a-Raw-2647-cells-were.png)
CGRP inhibits LPS induced-osteoclast differentiation in vitro.: (a) Raw... | Download Scientific Diagram
![Dihydroartemisinin attenuates lipopolysaccharide-induced osteoclastogenesis and bone loss via the mitochondria-dependent apoptosis pathway | Cell Death & Disease Dihydroartemisinin attenuates lipopolysaccharide-induced osteoclastogenesis and bone loss via the mitochondria-dependent apoptosis pathway | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fcddis.2016.69/MediaObjects/41419_2016_Article_BFcddis201669_Fig1_HTML.jpg)
Dihydroartemisinin attenuates lipopolysaccharide-induced osteoclastogenesis and bone loss via the mitochondria-dependent apoptosis pathway | Cell Death & Disease
![Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling | BMC Immunology | Full Text Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling | BMC Immunology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12865-021-00409-9/MediaObjects/12865_2021_409_Fig1_HTML.png)
Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling | BMC Immunology | Full Text
![Frontiers | The Potential Role of RP105 in Regulation of Inflammation and Osteoclastogenesis During Inflammatory Diseases Frontiers | The Potential Role of RP105 in Regulation of Inflammation and Osteoclastogenesis During Inflammatory Diseases](https://www.frontiersin.org/files/Articles/713254/fcell-09-713254-HTML/image_m/fcell-09-713254-g004.jpg)
Frontiers | The Potential Role of RP105 in Regulation of Inflammation and Osteoclastogenesis During Inflammatory Diseases
![Artemether attenuates LPS-induced inflammatory bone loss by inhibiting osteoclastogenesis and bone resorption via suppression of MAPK signaling pathway | Cell Death & Disease Artemether attenuates LPS-induced inflammatory bone loss by inhibiting osteoclastogenesis and bone resorption via suppression of MAPK signaling pathway | Cell Death & Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41419-018-0540-y/MediaObjects/41419_2018_540_Fig1_HTML.jpg)
Artemether attenuates LPS-induced inflammatory bone loss by inhibiting osteoclastogenesis and bone resorption via suppression of MAPK signaling pathway | Cell Death & Disease
![Docosahexaenoic Acid Inhibits Inflammation-Induced Osteoclast Formation and Bone Resorption in vivo Through GPR120 by Inhibiting TNF-α Production in Macrophages and Directly Inhibiting Osteoclast Formation | Semantic Scholar Docosahexaenoic Acid Inhibits Inflammation-Induced Osteoclast Formation and Bone Resorption in vivo Through GPR120 by Inhibiting TNF-α Production in Macrophages and Directly Inhibiting Osteoclast Formation | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/373798a382af447512798e2dad32dc7a7fe842b9/11-Figure7-1.png)
Docosahexaenoic Acid Inhibits Inflammation-Induced Osteoclast Formation and Bone Resorption in vivo Through GPR120 by Inhibiting TNF-α Production in Macrophages and Directly Inhibiting Osteoclast Formation | Semantic Scholar
![Thonzonium bromide inhibits RANKL-induced osteoclast formation and bone resorption in vitro and prevents LPS-induced bone loss in vivo - ScienceDirect Thonzonium bromide inhibits RANKL-induced osteoclast formation and bone resorption in vitro and prevents LPS-induced bone loss in vivo - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S000629521600112X-fx1.jpg)
Thonzonium bromide inhibits RANKL-induced osteoclast formation and bone resorption in vitro and prevents LPS-induced bone loss in vivo - ScienceDirect
![Osteoclastogenesis in periodontal diseases: Possible mediators and mechanisms. - Abstract - Europe PMC Osteoclastogenesis in periodontal diseases: Possible mediators and mechanisms. - Abstract - Europe PMC](https://europepmc.org/articles/PMC7329621/bin/nihms-1568781-f0001.jpg)
Osteoclastogenesis in periodontal diseases: Possible mediators and mechanisms. - Abstract - Europe PMC
![IJMS | Free Full-Text | Synovial Fluid Interleukin-16 Contributes to Osteoclast Activation and Bone Loss through the JNK/NFATc1 Signaling Cascade in Patients with Periprosthetic Joint Infection IJMS | Free Full-Text | Synovial Fluid Interleukin-16 Contributes to Osteoclast Activation and Bone Loss through the JNK/NFATc1 Signaling Cascade in Patients with Periprosthetic Joint Infection](https://www.mdpi.com/ijms/ijms-21-02904/article_deploy/html/images/ijms-21-02904-g006.png)